Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study

This publication has 24 references indexed in Scilit:

• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  American Journal of Obstetrics and Gynecology, 2007
• Identifying Women With Cervical Neoplasia
  JAMA, 1999
• Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV)
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
• Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma
  Cancer, 1996
• Human papillomavirus testing in primary cervical screening
  The Lancet, 1995
• A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors
  Obstetrics & Gynecology, 1995
• Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
  American Journal of Obstetrics and Gynecology, 1995
• 3 Human papillomavirus tests
  Bailliere's Clinical Obstetrics and Gynaecology, 1995
• Interim Guidelines for Management of Abnormal Cervical Cytology
  JAMA, 1994
• Papillomaviruses in human cancers
  Molecular Carcinogenesis, 1988